Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2026-02-03 @ 1:43 AM
Study NCT ID:
NCT02034292
Status:
TERMINATED
Last Update Posted:
2019-02-15
First Post:
2013-12-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of APD-791 With Aspirin and/or Clopidogrel
Sponsor:
IlDong Pharmaceutical Co Ltd
Organization:
Study Overview
Official Title:
Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin
Status:
TERMINATED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor Decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TG1C
Brief Summary:
Evaluating safety and PK parameter of APD-791 when co-administered with aspirin and clopidogrel.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: